CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-23 | Grossman William Chief Medical Officer | Sale | −4,133 | $31.37 | $130K | 6,717 |
| 2021-03-31 | FALBERG KATHRYN E Director | Purchase | +20,000 | $28.35 | $567K | 102,106 |
| 2021-03-16 | Grossman William Chief Medical Officer | Sale | −2,127 | $35.03 | $75K | 10,850 |
| 2021-03-16 | Jarrett Jennifer Chief Operating Officer | Sale | −8,661 | $35.03 | $303K | 116,973 |
| 2021-02-01 | ROSEN TERRY J Chief Executive Officer | Gift | −311,900 | 0 | ||
| 2021-01-31 | GILEAD SCIENCES INC 10% owner | Purchase | +5,650,000 | $39.00 | $220.3M | 13,913,029 |
| 2021-01-19 | Tang Carolyn C. General Counsel | Grant or award | +12,538 | 19,886 | ||
| 2021-01-19 | Tang Carolyn C. General Counsel | Grant or award · Stock Option (right to buy) | +75,225 | 75,225 | ||
| 2021-01-19 | ROSEN TERRY J Chief Executive Officer | Grant or award | +45,000 | 234,393 | ||
| 2021-01-19 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +280,000 | 280,000 | ||
| 2021-01-19 | Jarrett Jennifer Chief Operating Officer | Grant or award | +400,000 | 500,634 | ||
| 2021-01-19 | Jaen Juan C. President | Grant or award | +19,375 | 208,768 | ||
| 2021-01-19 | Jaen Juan C. President | Grant or award · Stock Option (right to buy) | +116,250 | 116,250 | ||
| 2021-01-19 | Grossman William Chief Medical Officer | Grant or award | +18,750 | 25,477 | ||
| 2021-01-19 | Grossman William Chief Medical Officer | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2021-01-19 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +12,500 | 17,500 | ||
| 2021-01-19 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2020-12-17 | PERLMAN ANDREW J Director | Grant or award | +4,500 | 4,500 | ||
| 2020-12-17 | PERLMAN ANDREW J Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2020-12-16 | Grossman William Chief Medical Officer | Sale | −2,117 | $31.35 | $66K | 6,727 |
Page 19 of 20 · 381 trades